6,8-Bis(Benzylthio)Octanoic Acid
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 6,8-Bis(Benzylthio)Octanoic Acid, covering 2018-07-03 to 2018-07-03. Get the full timeline:
Most recent: Clinical Trial Update: 6,8-Bis(Benzylthio)Octanoic Acid, Cytarabine, and Daunorubicin Hydrochloride in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 1, Phase 2]